Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 13.03.2025
LAIQON AG
Company Name:
LAIQON AG
ISIN:
DE000A12UP29
Reason for the research:
Update
Recommendation:
Buy
from:
13.03.2025
Target price:
EUR 7.40
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
Prelims show solid underlying growth; all eyes on scaling AuM
LAIQON released FY’24 sales and EBITDA preli [ … ]
Thu, 13.03.2025
Nynomic AG
Company Name:
Nynomic AG
ISIN:
DE000A0MSN11
Reason for the research:
Update
Recommendation:
Buy
from:
13.03.2025
Target price:
EUR 34.50
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Q4 prelims in line, returning to growth in FY25; chg. est.
Topic: Nynomic released preliminary Q4 figures [ … ]
Thu, 13.03.2025
Mensch und Maschine Software SE
High future investments and record cashflow
- Dividend 185 Cents / +12% - 75 Cents payable pre-tax
- Mid-term target: doubling earnings in 4-5 years
Wessling, March 13, 2025 – Mensch und Maschine Software SE (MUM - ISIN DE0006580806), a CAD/CAM/BIM specialist company, today presents its Annual Report 2024, describing how M+M has laid a very good fo [ … ]
Thu, 13.03.2025
ecotel communication ag
Sales grow by 8% to 115.5 million EUR
Operating EBITDA grows by 5% to 9.5 million EUR,
consolidated profit of 2.0 million EUR, earnings per share of 0.57 EUR
Düsseldorf, 13.March 2025
In the 2024 financial year, ecotel has shown growth despite the challenging economic environment. Conditions have resulted in a solid outcome. Group sales in [ … ]
Thu, 13.03.2025
cyan AG
cyan AG achieves guidance for the 2024 financial year and plans further strong corporate growth
Consolidated operating sales of EUR 7.1 million achieved
Growth target of 50 % achieved compared to the previous year
Significant improvement in EBITDA to EUR -1.6 to -1.5 million
Investments in development and sales planned for further growth
Munic [ … ]
Thu, 13.03.2025
MLP SE
FY 2024: Earnings at upper end of forecast, revenue above one billion euros for the first time – significant growth planned up to 2028
FY 2024: Total revenue increased on a very broad basis and for the eleventh year in succession, new all-time high of EUR 1,067 million (plus 10 percent) achieved, compound annual growth rate (CAGR) of 9 percent sin [ … ]
Thu, 13.03.2025
Hannover Rück SE
Hannover Re significantly increases dividend after a highly successful 2024 financial year
Group net income rises by 28% to EUR 2.3 billion and reaches guidance, which had been revised higher in autumn 2024
Return on equity increases to 21.2% and clearly exceeds strategic target
Reinsurance revenue increases by 7.9% to EUR 26.4 billion
Opera [ … ]
Thu, 13.03.2025
Masterflex SE
Masterflex SE achieves record operating result in financial year 2024 according to preliminary figures
Consolidated sales revenue of EUR 98.1 million according to preliminary figures (previous year: EUR 101.1 million)
Record EBITDA of EUR 18.2 million (previous year: EUR 17.9 million) and operating EBIT of EUR 12.7 million (previous year: EUR 12. [ … ]
Thu, 13.03.2025
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
HealthCare Royalty and Heidelberg Pharma amend royalty financing agreement to provide for USD 20 million payment
Heidelberg Pharma extends cash runway into 2027
Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company [ … ]
Thu, 13.03.2025
grenke AG
grenke generates a EUR 70.2 million profit in 2024 and maintains growth trajectory
Group earnings 2024 reach EUR 70.2 million (2023: EUR 86.7 million)
Proposed dividend of EUR 0.40 per share (2023: EUR 0.47)
Guidance for 2025: Leasing new business between EUR 3.2 and EUR 3.4 billion and Group earnings in the range of EUR 71 to 81 million
Bade [ … ]